Mark Eisner

Mark Eisner is a highly accomplished professional with a diverse educational background and a wealth of experience in the fields of epidemiology, biostatistics, clinical medicine, and product development.

He holds a Master's in Public Health with a focus on Epidemiology and Biostatistics from the University of California, Berkeley, School of Public Health. Additionally, he pursued a Medical Doctor degree from the University of Pennsylvania School of Medicine and an undergraduate degree in Human Biology from Stanford University.

Throughout his career, Mark has held key positions in various prestigious organizations. He served as a Senior Vice President at Genentech, where he also held roles such as Vice President and Global Head of Respiratory, Actemra, ID, and Metabolism Clinical Development. His contributions to Genentech were substantial, showcasing his expertise in clinical development and leadership.

Prior to his tenure at Genentech, Mark Eisner was deeply involved in academia, holding positions such as Professor of Clinical Medicine at the University of California, San Francisco. His academic background also includes roles such as Professor of Medicine, Fellow in Pulmonary and Critical Care Medicine, and Chief Medical Resident at the same institution.

Mark's extensive experience in the pharmaceutical and medical fields is further underlined by his involvement in the American Thoracic Society, where he served on the Board of Directors. His contributions to the field have been recognized through his various leadership roles and academic appointments, reflecting his commitment to advancing healthcare and medicine.

Currently, Mark Eisner continues to make an impact in the healthcare industry as a Member of the Board of Directors at the Genentech Foundation. His rich background in clinical medicine, product development, and academic research positions him as a versatile and accomplished professional in the field of medicine and biostatistics.